The big question: Will cancer immune therapy work for me?

SAN DIEGO (AP) – Dennis Lyon was a genetic train wreck. Cancer was ravaging his liver, lungs, bones and brain, and tests showed so many tumor mutations that drugs targeting one or two wouldn’t do much good. It seemed like very bad news, yet his doctors were encouraged.

U.S. stocks were slightly higher in late-afternoon trading Tuesday, on course to add to the market’s modest gains from the day before. Banks, insurers and other financial companies led the gainers. Technology stocks also helped lift the market, while health care companies lagged the most.